Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia
Timo Rieg(University of South Florida), Volker Vallon(Unknown), Scott C. Thomson(UC San Diego Health System), Kenneth A. Platt(Lexicon Pharmaceuticals (United States)), Maria Gerasimova(VA San Diego Healthcare System), Takahiro Masuda(Jichi Medical University), Hermann Koepsell(University of Würzburg), Eric Mayoux(Boehringer Ingelheim (Germany)), David R. Powell(Lexicon Pharmaceuticals (United States))
Cited by 308
Related Papers
Glucose transporters in brain in health and disease
|Pflügers Archiv - European Journal of Physiology|2020|520
SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice
|American Journal of Physiology-Renal Physiology|2013|481
Renal Ca2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5
|Journal of Clinical Investigation|2003|432
Renal Ca2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5
|Journal of Clinical Investigation|2003|404
SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy
|Journal of Biological Chemistry|2017|302